CNO Financial Group stock added almost 3% today to close at $55.09, extending a strong multi month run as investors reacted to what looked like a cleaner, more profitable insurance engine in Q2. The headline was simple. Operating earnings power stepped up while the balance sheet stayed within stated capital and leverage targets.
Short term traders are focusing on the Q2 earnings per share jump and the raised full year operating EPS guidance to $4.60 to $4.80. Long term holders are more likely to focus on whether this improved profitability and valuation gap can persist over several years.
Like the cleaner earnings picture at CNO Financial Group but want a wider set of insurers with resilient balance sheets and solid fundamentals to compare it against? Take a look at our curated list of solid balance sheet and fundamentals stocks (45 results).
Prefer clean charts over scrolling through rows of figures and dense commentary? See CNO Financial Group's full financial picture, including an at a glance view of its recent earnings quality and profitability trends in the interactive company report for CNO Financial Group.
The bullish pitch on CNO Financial Group is that a cleaner, higher quality earnings engine is taking hold, powered by annuity and health growth, tech investment and fee based expansion. Q2 hits several of those milestones. Operating EPS grew 45% and full year guidance moved up to US$4.60 to US$4.80, which points to better earnings power than investors had baked in a few months ago. Insurance product margins improved across key lines and new annualized premiums rose 7% with long streaks of consecutive sales and agent growth in both Consumer and Worksite. Medicare Supplement and supplemental health posted strong gains and annuity collected premiums reached a record. Expense ratio guidance tightened slightly lower at the top end and capital metrics stayed within targets. That combination supports the idea of more repeatable earnings rather than a one off spike.
The main bear argument is that CNO Financial Group is enjoying a hot streak driven by one offs and macro help while longer term fundamentals remain mixed. Q2 gives bears some support. Part of the margin strength came from reserve releases in Medicare Supplement and closed annuity blocks. Management explicitly called out uncertainty around how durable the long term care and Medicare morbidity experience will be, with an annual review still ahead. Trailing 12 month net profit margin stood at 6.0% versus 6.6% a year earlier, so the stronger quarter has not yet translated into higher through cycle profitability. Life NAP declined 9% as the company repositions direct to consumer marketing, which shows the distribution transition is not friction free. Against that, 16 quarters of sales growth and higher investment income push back on the idea that the story is purely cyclical.
Reveal where the surface looks calm but the models start to disagree on CNO Financial Group's next few years and see where the consensus break might sit across revenue, EPS and cash flow by accessing the analyst estimates for CNO Financial Group.If the sharper earnings picture at CNO Financial Group has your attention, register for free with Simply Wall St and add it to a Watchlist so you can track the share price against fair value and wait for a setup that fits your plan. After you decide to build a position, keep your focus with the Portfolio Command Center that cuts through noise and highlights only the key developments affecting your holdings. For a longer term edge, tap into the Community to compare your thesis with other investors and spot shifts in sentiment early. This combination helps you surface potential catalysts and risks ahead of the crowd and stay a step in front of the broader market.
Fresh stock ideas can move from quiet buildup to full breakout faster than most investors expect. Spot under the radar momentum while it matters and get in early.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com